BioBytes: IBM Deal Helps Moderna Maintain Cutting-Edge In Tech

Welcome to In Vivo’s new AI-focused blog, BioBytes, providing news and insight on the growing role of artificial intelligence in biopharma. Moderna is teaming up with IBM to integrate quantum computing into its operations. The partnership should accelerate and optimize drug discovery and development while continuing to evolve Moderna's digital-first approach.

Bio Bytes
• Source: Shutterstock

More from Innovation

More from In Vivo